Microwave triggered multifunctional nanoplatform for targeted photothermal-chemotherapy in castration-resistant prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Microwave triggered multifunctional nanoplatform for targeted photothermal-chemotherapy in castration-resistant prostate cancer

Published:2023-02-27 Issue:7 Volume:16 Page:9688-9700
ISSN:1998-0124
Container-title:Nano Research
language:en
Short-container-title:Nano Res.

Author:

Liu Pengyuan,Wu Yajun,Xu Xiaogang,Fan Xudong,Sun Chuan,Chen Xiaojie,Xia Jindan,Bai Shiting,Qu Li,Lu Huasong,Wu Jing,Chen Jun,Piao Ji-Gang,Wu Zhibing

Publisher

Springer Science and Business Media LLC

Subject

Electrical and Electronic Engineering,General Materials Science,Condensed Matter Physics,Atomic and Molecular Physics, and Optics

Link

https://link.springer.com/content/pdf/10.1007/s12274-023-5541-1.pdf

Reference42 articles.

1. Siegel, R. L.; Miller, K. D.; Fuchs, H. E.; Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 2022, 72, 7–33.

2. Sweeney, C. J.; Martin, A. J.; Stockler, M. R.; Begbie, S.; Chi, K. N.; Chowdhury, S.; Coskinas, X.; Frydenberg, M.; Hague, W. E.; Horvath, L. G. et al. Overall survival of men with metachronous metastatic hormone-sensitive prostate cancer treated with enzalutamide and androgen deprivation therapy. Eur. Urol. 2021, 80, 275–279.

3. Petrylak, D. P.; Ratta, R.; Gafanov, R.; Facchini, G.; Piulats, J. M.; Kramer, G.; Flaig, T. W.; Chandana, S. R.; Li, B.; Burgents, J. et al. KEYNOTE-921: Phase III study of pembrolizumab plus docetaxel for metastatic castration-resistant prostate cancer. Future Oncol. 2021, 17, 3291–3299.

4. Cornford, P.; van den Bergh, R. C. N.; Briers, E.; van den Broeck, T.; Cumberbatch, M. G.; de Santis, M.; Fanti, S.; Fossati, N.; Gandaglia, G.; Gillessen, S. et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: Treatment of relapsing and metastatic prostate cancer. Eur. Urol. 2021, 79, 263–282.

5. Teo, M. Y.; Rathkopf, D. E.; Kantoff, P. Treatment of advanced prostate cancer. Annu. Rev. Med. 2019, 70, 479–499.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of N⁶‑methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review);Oncology Reports;2024-05-13

2. Microwave hyperthermia enhances radiosensitization by decreasing DNA repair efficiency and inducing oxidative stress in PC3 prostatic adenocarcinoma cells;International Journal of Hyperthermia;2024-04-07

3. Nanotherapeutics for prostate cancer treatment: A comprehensive review;Biomaterials;2024-03

4. Advances in nanotechnology-based targeted-contrast agents for computed tomography and magnetic resonance;Science Progress;2024-01

5. Advancements in modifying the efficacy of immunotherapies through the thermal effects of nanomaterials;Nano TransMed;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3